Rights and permissions
About this article
Cite this article
Adenoviral p53 gene therapy promising in phase I cancer trials. Inpharma Wkly. 1141, 8 (1998). https://doi.org/10.2165/00128413-199811410-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199811410-00019